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Familial Adenomatous Polyposis Syndrome (FAP) is an
autosomal dominant inherited hereditary colorectal
cancer syndrome that is characterized by hundreds to
thousands of adenomatous colonic polyps and, without
treatment and close surveillance, confers a high lifetime
risk of colon cancer. Polyps usually develop in adoles-
cence and virtually all will develop polyps by age 30. It
is caused by a mutation in the Adenomatous Polyposis
coli (APC) gene which is responsible for tumor suppres-
sion and controls apoptosis. While benign fundic gland
polyps are common, gastric cancer is rare in the
Western population. MYH Associated Polyposis Syn-
drome (MAP) is an autosomal recessive disease caused
by biallelic mutations in the MYH gene which is part of
the base excision repair system. Patients with MAP
exhibit an attenuated form of polyposis with 10’st o
100’s of adenomatous polyps and have a later age of
onset, typically 10 years later than FAP. Currently to be
diagnosed with MAP patients must carry biallelic muta-
tions though recent studies have described similar colon
cancer risks for monoallelic carriers.
We report on a case of a 65 year old woman with an
APC mutation positive FAP (de novo) who also carries
a monoallelic mutation in the MYH gene G382D that
developed metastatic gastric cancer within a year of a
clear CT scan. She had undergone a colectomy with
IRA in her 20’s and had been followed by yearly endo-
scopic surveillance that demonstrated polyps in the
remaining rectum as well as adenomatous duodenal
polyps and gastric polyps with no evidence of malig-
nancy. At 61 she was converted to a I-Pouch and con-
tinued with appropriate surveillance. At age 64
Spieglman Stage III duodenal adenomatosis was
detected and EGDs were done every 3 months. In
March 2008 she presented to the ER with epigastric
pain, hematochezia and hemetemesis following an EGD
and polypectomy earlier that day. A CT of the chest,
abdomen and pelvis did not reveal any abnormalities.
She continued to be monitored every 3 months and in
March 2009 she had progressed to Spieglman Stage IV.
Biopsies were obtained from the duodenal adenomas
and were negative for high grade dysplasia. Two months
later a CT scan revealed abnormal nodules in the liver.
A diagnosis of metastatic gastric cancer was made
following further studies.
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